Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Moreno-Smith, Myrthala*" or (type exact bookEditor and editor="Moreno-Smith, Myrthala*")

Add to list
- Journal Article
- A2
- open access
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Alan Van Goethem (UGent) , Jill Deleu (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Fjoralba Zeka (UGent) , Fleur Demuynck (UGent) , Eveline Barbieri, Franki Speleman (UGent) , et al.

(2023) NAR CANCER. 5(1).
Add to list
Longitudinal evaluation of murine serum microRNAs as biomarkers for neuroblastoma burden and therapeutic TP53 reactivation

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Fjoralba Zeka (UGent) , Fleur Demunck, Eveline Barbieri, Franki Speleman (UGent) , Pieter Mestdagh (UGent) , et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
- Journal Article
- A1
- open access
Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Myrthala Moreno-Smith, Sanjeev A Vasudevan, Eveline Barbieri, Franki Speleman (UGent) , Jason Shohet, Jo Vandesompele (UGent) and Tom Van Maerken (UGent)

(2017) ONCOTARGET. 8(34). p.57047-57057
Add to list
- Journal Article
- A1
- open access
Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Celine Everaert (UGent) , Myrthala Moreno-Smith, Liselot Mus (UGent) , Eveline Barbieri, Franki Speleman (UGent) , Pieter Mestdagh (UGent) , Jason Shohet, Tom Van Maerken (UGent) , et al.

(2016) SCIENTIFIC REPORTS. 6.

Academic Bibliography

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation

Longitudinal evaluation of murine serum microRNAs as biomarkers for neuroblastoma burden and therapeutic TP53 reactivation

Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma

Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples

Contents

Support

Contact